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Edited by Sandro SonninoAbstract In yeast, the aminoalcohol phosphotransferases
Ept1p and Cpt1p catalyze the ﬁnal steps in the CDP-ethanol-
amine and CDP-choline routes leading to phosphatidylethanol-
amine (PE) and phosphatidylcholine (PC), respectively. To
determine how these enzymes contribute to the molecular species
proﬁles of PE and PC in vivo, wild-type, cpt1D, and ept1D cells
were pulse labeled with deuterated ethanolamine and choline.
Analysis of newly synthesized PE and PC using electrospray
ionization tandem mass spectrometry revealed that PE and PC
produced by Ept1p and Cpt1p have diﬀerent species composi-
tions, demonstrating that the enzymes consume distinct sets of
diacylglycerol species in vivo. Using the characteristic phospho-
lipid species proﬁles produced by Ept1p and Cpt1p as molecular
ﬁngerprints, it was also shown that in vivo CDP-monomethyl-
ethanolamine is preferentially used as substrate by Ept1p,
whereas CDP-dimethylethanolamine and CDP-propanolamine
are converted by Cpt1p.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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labeling; Electrospray ionization tandem mass spectrometry1. Introduction
Phosphatidylethanolamine (PE) and phosphatidylcholine
(PC) are two of the major membrane lipid constituents in
eukaryotic cells. In the model eukaryote Saccharomyces cere-
visiae, these phospholipid classes together account for 60–75%
of the total phospholipid content (see e.g. [1]), and they share a
highly interconnected metabolic relationship [2]. In yeast, the
biosynthesis of PE proceeds mainly via decarboxylation of
phosphatidylserine (PS) [3,4], and the subsequent triple
methylation of PE leads to the production of PC [5]. Apart* Corresponding author. Fax: +31-30-2533969.
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Abbreviations: PC, phosphatidylcholine; PE, phosphatidylethanol-
amine; (P)MME, (phosphatidyl)monomethylethanolamine; (P)DME,
(phosphatidyl)dimethylethanolamine; PPrN, phosphatidylpropanol-
amine; DAG, diacylglycerol; ESI-MS/MS, electrospray ionization
tandem mass spectrometry
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i.e., the CDP-ethanolamine and the CDP-choline routes
yielding PE and PC, respectively [6]. In the Kennedy pathways
an aminoalcohol, choline or ethanolamine, is phosphorylated
by a kinase, and then converted to a CDP-aminoalcohol by a
CTP-phosphoaminoalcohol cytidylyltransferase. In the third
and ﬁnal step mediated by the aminoalcohol phosphotrans-
ferases Cpt1p and Ept1p, the phosphoaminoalcohol moiety is
transferred to diacylglycerol (DAG) (for review see [2]). Cpt1p
and Ept1p exhibit 54% sequence homology [7], and the en-
coding genes most likely arose from a common ancestor by
whole genome duplication [8].
In yeast strains with defects in PS decarboxylation or in PE
methylation, the CDP-ethanolamine and CDP-choline path-
ways fulﬁll the requirements for PE and PC, respectively,
provided that ethanolamine and choline are supplied in the
medium [3,9]. The notion that the CDP-choline routes serves
primarily as an auxiliary pathway in the synthesis of PC in
wild-type yeast was proven incorrect, as this biosynthetic
pathway also contributes to PC formation in the absence of
exogenous choline [10]. By recycling degradation products of
PC, the CDP-choline route may contribute to maintaining the
proper PC species composition, i.e., the proﬁle of acyl chains
in PC [11]. Very little is known about the physiological role of
the CDP-ethanolamine route. It may recycle ethanolamine and
ethanolaminephosphate derived from PE and sphingoid base
phosphates, respectively, into PE [12]. Both Kennedy path-
ways, in particular the membrane-associated enzymes Ept1p
and Cpt1p consume DAG, which has been implicated in the
yeast secretory pathway (reviewed in [2,13,14]). Whereas in-
activation of genes in the CDP-choline pathway bypasses the
essential function of Sec14p, inactivation of genes in the CDP-
ethanolamine pathway does not [15,16].
The substrate speciﬁcities of Ept1p and Cpt1p toward a
limited set of DAG species and diﬀerent CDP-aminoalcohols
have been characterized in vitro using microsomes containing
either one of the two enzymes in a mixed micellar assay [17,18].
In the presence of detergent both enzymes were found to ex-
hibit broad but distinct speciﬁcities for their DAG substrates
[17,18]. Here, the predictive value of the in vitro data for the in
vivo condition was tested, by comparing the utilization of
substrates by Ept1p and Cpt1p, in intact yeast cells, in order to
analyze how the Kennedy pathways contribute to the PE andation of European Biochemical Societies.
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spectrometry (ESI-MS/MS) in phospholipid analysis [19], in
combination with stable isotope labeling [11,20], it is now
possible to examine the substrate use of these enzymes in vivo.
Pulse labeling yeast cells with deuterated ethanolamine and
choline revealed that Ept1p and Cpt1p utilize diﬀerent sets of
DAG species. In addition, the aminoalcohol speciﬁcities of
Ept1p and Cpt1p in vivo have been addressed. The results are
discussed in the light of the substrate selectivity of the enzymes
in vitro, and of the physiological functions of both phospho-
lipid biosynthetic pathways.2. Materials and methods
2.1. Materials
Yeast extract was supplied by Sigma (St. Louis, MO). Yeast Ni-
trogen Base (YNB) without amino acids was obtained from Difco
(Detroit, MI). Deuterium labeled (D4)-ethanolamine and (D13)-choline
were purchased from Cambridge Isotope Laboratories (Andover,
MA). 2-(Methylamino)-ethanolamine was supplied by Fluka (Buch,
Switzerland), N,N-dimethylethanolamine and 3-amino-1-propanol
were from Aldrich (Milwaukee, WI). All other chemicals were of an-
alytical grade.
2.2. Yeast strains
The parental strain S. cerevisiae BY4742 (MATa his3D1 leu2D0
lys2D0 ura3D0) and the congenic cho2D strain (cho2::KanMX) were
obtained from Research Genetics (Paisley, UK). The strains ept1D
(ept1::KanMX) and cpt1D (cpt1::KanMX) were from Euroscarf
(Frankfurt, Germany). The LEU2 marker [21] was introduced into the
cho2D strain to substitute for the OPI3 gene (nucleotides )11 to 621),
thereby generating the cho2Dopi3D strain (cho2::KanMX opi3::LEU2).
PCR was carried out to verify the correct integration of the LEU2
marker into the yeast genome.
2.3. In vivo deuterium pulse labeling of phospholipids
Yeast strains were cultured aerobically at 30 C in 0.8 L of semi-
synthetic lactate (SSL) medium [22] supplemented with 20 mg/L his-
tidine, 60 mg/L leucine, 230 mg/L lysine and 40 mg/L uracil. Lactate
was used as carbon source because of our interest in phospholipid
metabolism under conditions of optimal mitochondrial development.
The medium of the cho2Dopi3D strain was additionally supplemented
with 1.0 mM choline. Cells in the midlog phase of growth were har-
vested, washed with, and resuspended in 0.8 L of synthetic lactate (SL)
medium [0.67% YNB without amino acids, 2% lactate, 0.1% glucose,
pH 5.5] with the supplements mentioned above except choline. In order
to obtain suﬃcient incorporation of label to enable accurate mass
spectrometry analysis, cells were pulsed with 2.0 mM (D4)-ethanol-
amine for 30 min, whereas 10 min labeling with 0.2 mM (D13)-choline
was suﬃcient to detect labeled PC (not shown). Pulsing the cells with
(D13)-choline for 30 min instead of 10 min, did not signiﬁcantly aﬀect
the species proﬁle of labeled PC. The cho2Dopi3D strain was also
pulsed with 4.0 mM monomethylethanolamine (MME) or 4.0 mM
dimethylethanolamine (DME) for 30 min, or with 20 mM propanol-
amine for 2 h. After the pulse, cellular processes were arrested by
adding an ice-cold mixture of KCN, NaF, and NaN3 to ﬁnal con-
centrations of 15 mM each. Cell pellets corresponding to 100 OD600
units were homogenized using glass beads and phospholipids were
extracted as described [23].
2.4. ESI-MS/MS
Lipid extracts were dissolved at 0.5 mM total phospholipid-phos-
phorus in CHCl3/CH3OH/H2O (2:15:3, v/v/v) containing 1.0% (v/v)
formic acid. Samples were analyzed on a Quattro Ultima triple
quadrupole MS instrument (Micromass, Manchester, UK) equipped
with a nano-electrospray ion source, and introduced into the instru-
ment at a ﬂow rate of 50 nL/min. The capillary and cone voltages
were set at 1.5 kV and 30 V, respectively, and all measurements were
performed in the positive ion mode. Collision-activated dissociation
was applied using argon and collision energies of 30 eV. The [M+H]þ
and [M+Na]þ adducts of unlabeled PE, (D4)-labeled PE, phosphati-dylmonomethylethanolamine (PMME), phosphatidyldimethyletha-
nolamine (PDME), and phosphatidylpropanolamine (PPrN) were
monitored by neutral loss scanning for m=z 141, 145, 155, 169, and 155,
respectively. The [M+H]þ ions of unlabeled and D13-labeled PC were
detected by parent ion scanning at m=z 184 and 197, respectively. Data
were collected by averaging 40–100 repetitive scans with a scan time of
10 s, obtained from at least two independent experiments. For quan-
tiﬁcation, ESI-MS/MS data were processed using Masslynx NT soft-
ware (Micromass), thereby taking into account the three most
prominent isotopic signals of each molecular species. Correction for
the inverse relationship between mass and signal response of the MS
instrument was performed as described previously [11,19]. This cor-
rection was not applied to spectra of the labeled phospholipids, since
these lipids were introduced into the instrument at low concentrations
(<0.005 mM). In that concentration range the instrument response was
found to be virtually independent of the acyl chain length in the rel-
evant m=z range (cf. [24]).3. Results
3.1. Comparison of the species compositions of newly
synthesized PE and PC via the Kennedy pathways
In order to monitor the molecular species composition of
newly synthesized PE and PC, wild-type yeast cells were pulse
labeled with (D4)-ethanolamine and (D13)-choline, respec-
tively. The ESI-MS/MS spectrum of (D4)-PE obtained after
30 min labeling with (D4)-ethanolamine revealed the presence
of 34:2, 34:1, 32:2, and 32:1 species (Fig. 1A), that presented
paired combinations of C16:0, C16:1, C18:0, and C18:1, the
predominant acyl chains in yeast [25]. Although the PE syn-
thesized via the CDP-ethanolamine pathway can be used for
the formation of PC via methylation [16], parent ion scanning
at m=z 188 did not reveal signiﬁcant conversion of (D4)-PE to
(D4)-PC upon 30 min labeling with (D4)-ethanolamine (data
not shown). This indicates that there is no appreciable
methylation of the CDP-ethanolamine route derived PE un-
der the conditions used. The (D4)-PE species composition was
quantiﬁed and compared to that of (D13)-PC newly synthe-
sized via the CDP-choline route [11], revealing that the PE
species proﬁle is diﬀerent from that of PC (Fig. 1B). Whereas
34:2 dominated the species proﬁle of (D4)-PE, 32:2 was the
major species of newly synthesized (D13)-PC (Fig. 1B). These
ﬁndings demonstrate that Ept1p and Cpt1p consume distinct
sets of DAG species to produce PE and PC in vivo, respec-
tively. Both proﬁles of newly synthesized (D4)-PE and D9-PC
diﬀered from the corresponding steady-state species proﬁles
(cf. [11]), indicating that PS decarboxylation and PE meth-
ylation are major contributors to the steady-state molecular
compositions of PE and PC, respectively. In addition, re-
modeling by acyl chain exchange could contribute to the
steady state species proﬁles as was recently demonstrated for
PC [11].
Whereas the ﬁnal step in the CDP-ethanolamine route
proceeds exclusively via Ept1p, both Ept1p and Cpt1p have
been reported to be capable of transferring phosphocholine to
DAG both in vitro [26,27], and in vivo, with the relative
contribution of Ept1p to PC synthesis in vivo depending on the
strain background [10,28]. To evaluate the contribution of
both aminoalcohol phosphotransferases to PC production in
BY4742, and to assess the role of the CDP-aminoalcohol
substrate in the speciﬁcity of Ept1p for DAG species, ept1D
and cpt1D cells were examined in pulse labeling experiments.
ESI-MS/MS analysis showed that the species composition of
(D13)-PC produced in ept1D cells via Cpt1p was similar to that
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Fig. 2. The species proﬁles of (D13)-PC (black, means S.D., n ¼ 3)
synthesized by Cpt1p in ept1D, and of (D13)-PC (gray bars,
meansS.D., n ¼ 3) and (D4)-PE (white, meansS.D., n ¼ 3) syn-
thesized by Ept1p in cpt1D yeast cells. Cells were pulsed with (D13)-
choline for 10 min and with (D4)-ethanolamine for 30 min, and total
lipid extracts were subjected to ESI-MS/MS in the parent ion scan
mode (m=z 197), and neutral loss mode (m=z 144), respectively.
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Fig. 1. The CDP-ethanolamine and the CDP-choline routes use dis-
tinct sets of DAG species in wild-type yeast in vivo. (A) ESI-MS/MS
spectrum of newly synthesized (D4)-PE in wild-type yeast labeled with
(D4)-ethanolamine for 30 min. (D4)-PE species were detected by neu-
tral loss scanning for m=z 145. Both [M+H]þ and asterisk-marked
[M+Na]þ PE species are shown. The unmarked peaks represent iso-
topic signals originating from the natural abundance of 13C. (B)
Quantiﬁcation of the species composition of (D4)-PE (white,
meansS.D., n ¼ 4) in wild-type yeast, compared to that of newly
synthesized (D13)-PC (black, means S.D., n ¼ 3) obtained by pulsing
cells for 10 min with (D13)-choline (taken from [11]).
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black bars). The species proﬁles of (D13)-PC and (D4)-PE
observed in cpt1D were similar (compare gray to white bars in
Fig. 2), and resembled that of (D4)-PE rather than that of
(D13)-PC in wild-type cells, except for signiﬁcant increases in
the relative amounts of the mono-unsaturated species at the
expense of the di-unsaturated species (cf. Fig. 1B, white bars).
The combined results indicate (i) that the nature of the CDP-
aminoalcohol substrate of Ept1p does not signiﬁcantly inﬂu-
ence its speciﬁcity for the DAG species used as lipid substrate;
(ii) that Cpt1p activity aﬀects the substrate use by Ept1p; (iii)
that Ept1p plays only a minor role in PC biosynthesis in wild-
type yeast in agreement with previous studies [10,29].
3.2. CDP-aminoalcohol speciﬁcity of Ept1p and Cpt1p in vivo
Apart from ethanolamine and choline, the Kennedy path-
ways can also use MME and DME as substrates to yield
PMME and PDME, respectively [17]. By adding MME or
DME to the culture medium, PC synthesis and growth of
cho2D yeast strains with an impaired PE methylation pathwayis restored to wild-type levels [9,30]. To investigate which of
the two aminoalcohol phosphotransferases is used in vivo for
the incorporation of the aminoalcohols MME and DME into
phospholipids, a cho2Dopi3D strain was used. This strain lacks
the phospholipid methyltransferases, thereby permitting the
detection of newly formed PMME and PDME, which are
short-lived intermediates in wild-type cells [31]. First, we an-
alyzed the steady-state species compositions of PE and PC and
observed that both proﬁles were very similar to those in the
parental wild-type strain (Fig. 3A) (cf. [11]). Subsequently,
cho2Dopi3D cells were pulse labeled with (D4)-ethanolamine
and (D13)-choline. As the compositions of new Kennedy
pathway derived PE and PC were comparable to those ob-
served in the wild-type strain (Figs. 1 and 3B), we concluded
that the cho2Dopi3D strain is a valid in vivo model to examine
the aminoalcohol preferences of Ept1p and Cpt1p.
When cho2Dopi3D cells were pulsed with MME, ESI-MS/
MS analysis revealed that the species proﬁle of PMME
strongly resembled that of newly formed PE (Fig. 3B). In
contrast, pulse labeling with DME resulted in a PDME species
composition matching that of newly synthesized PC. These
ﬁndings demonstrate that CDP-MME is preferentially used as
substrate by Ept1p, whereas CDP-DME is preferentially used
by Cpt1p in vivo.
3.3. Incorporation of propanolamine into phospholipids
Recently, it was shown that the artiﬁcial phospholipid PPrN
comprised up to 40% of total phospholipids in a psd1Dpsd2D
mutant supplemented with propanolamine, and strongly re-
duced the requirement for PE in yeast [32]. Here, we assessed
the metabolic origin of PPrN, using the characteristic species
proﬁles of the Kennedy pathway derived PE and PC as mo-
lecular ﬁngerprints. Cho2Dopi3D cells were labeled with pro-
panolamine and PPrN was monitored by neutral loss scanning
for the headgroup m=z 155 [32]. The composition of the PPrN
species strongly resembled that of newly formed PC (compare
Fig. 4 inset with Fig. 3B, black bars), demonstrating that
Cpt1p rather than Ept1p transfers the propanolaminephos-
phate moiety to DAG.
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Fig. 3. The speciﬁcity of Cpt1p and Ept1p for CDP-aminoalcohols in
vivo, assessed in a cho2Dopi3D strain. (A) Steady-state species com-
positions of PE and PC in cho2Dopi3D cells (S.D., nP 3). (B) Species
proﬁles of newly synthesized (D4)-PE, PMME, PDME, and (D13)-PC
in cho2Dopi3D cells pulse-labeled with (D4)-ethanolamine (white),
MME (light gray), DME (dark gray), and (D13)-choline (black), re-
spectively (mean variation, n ¼ 2). For experimental details, see
Section 2.
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Fig. 4. The species proﬁle of the artiﬁcial phospholipid PPrN reﬂects
synthesis by Cpt1p. ESI-MS/MS spectrum (neutral loss scanning for
m=z 155) of PPrN in a total lipid extract of cho2Dopi3D cells grown in
the presence of 20 mM propanolamine for 2 h. The inset depicts the
quantiﬁed species distribution (means variation, n ¼ 2).
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The substrate speciﬁcities of the aminoalcohol phospho-
transferases Ept1p and Cpt1p were investigated in vivo, by
pulse labeling yeast cells with deuterated lipid precursors and
analyzing the phospholipids by ESI-MS/MS. Ept1p and Cpt1p
were found to convert the endogenous DAG species to dif-
ferent extents, resulting in characteristic proﬁles of PE and PC
species newly synthesized by Ept1p on the one hand, and of PC
species produced by Cpt1p on the other.
The selectivity in the consumption of DAG species is most
likely the result of the speciﬁc catalytic properties of the en-
zymes and/or the availability of DAG substrates at the sites of
the enzymes. The DAG substrate speciﬁcities of Ept1p and
Cpt1p were studied previously in vitro in a mixed micellar
assay [18], in which the conversion of several synthetic DAG
species was tested. Ept1p showed the highest activity toward
di-unsaturated DAG species (36:2>32:2>34:1), consistent with
the present in vivo results (34:2>32:234:1, Figs. 1–3). Cpt1p
was found to preferentially use 32:2 in vitro (32:234:1>36:2)
[18], again in agreement with the in vivo data (32:2>32:1
34:2>34:1, Figs. 1–3).
However, when comparing the preferential use of DAG
species by Ept1p and Cpt1p in vivo versus in vitro, it should be
realized that two endogenous species, 32:1 and 34:2, were not
tested in vitro, and that the species composition of DAG
available to Ept1p and Cpt1p in vivo is not known and not
necessarily the same. The subcellular localizations of Ept1p
and Cpt1p have yet to be unambiguously resolved, in contrast
to those of their mammalian counterparts that have been lo-
calized to ER and Golgi, respectively [33]. Subcellular frac-
tionation studies in yeast showed an enrichment of Cpt1p
activity in microsomal fractions and Golgi [34–36]. More re-
cently, green ﬂuorescent protein-tagged versions of both Ept1p
and Cpt1p revealed punctate composite localizations, with
Ept1p co-localizing with a Golgi-marker [37]. If the subcellular
localizations of Ept1p and Cpt1p diﬀer like in higher eukary-
otes, the enzymes may have access to spatially separate pools
of DAG with diﬀerent species compositions, as the spontane-
ous intermembrane exchange of DAG is extremely slow [38].
Irrespective of the localization, our ﬁnding that the proﬁle of
DAG species converted by Ept1p was aﬀected by deleting the
CPT1 gene (Fig. 2) indicates that the putative separate DAG
pools do communicate.
The bypass of the essential function of Sec14p by genetic
inactivation of the CDP-choline pathway but not the CDP-
ethanolamine route has been attributed to an increased content
of DAG in the Golgi membranes, based on the assumption
that Cpt1p is localized in the Golgi membranes while Ept1p is
not [33]. Alternatively, based on the present results one could
postulate that the diﬀerential consumption of molecular spe-
cies of DAG by the two routes accounts for their functional
diﬀerence with respect to Sec14p defects, that is, if indeed
DAG is instrumental in bypassing defects in Sec14p function
(for a discussion see [2,13,39]).
The present data show that the proﬁle of PE species newly
synthesized by the CDP-ethanolamine route in wild-type cells
does not match the PE steady-state species distribution (cf.
[11]). It is very well possible that this pathway plays a physi-
ological role in maintaining the proper PE species distribution
via recycling of ethanolamine upon turnover of PE. Estab-
lishing such a role for the CDP-ethanolamine route awaits the
H.A. Boumann et al. / FEBS Letters 569 (2004) 173–177 177analysis of the PE species synthesized by decarboxylation of
PS in wild-type yeast and appropriate mutants. With respect to
the CDP-choline route we have previously shown that this
pathway may contribute signiﬁcantly to the newly synthesized
mono-unsaturated PC species in wild-type yeast [11].
The characteristic species proﬁles of the products of Ept1p
and Cpt1p were used as molecular ﬁngerprints for establishing
the speciﬁcities of Ept1p and Cpt1p toward the CDP-amino-
alcohol derivatives of MME and DME in vivo in a cho2Dopi3D
strain. A remarkable dichotomy was observed with PMME
carrying the species signature of Ept1p and PDME that of
Cpt1p. These results show that the nature of the CDP-am-
inoalcohol substrate does not inﬂuence the enzymes‘ speciﬁcity
for the DAG species. Whereas the selective incorporation of
CDP-MME by Ept1p in intact yeast cells is in agreement with
previous in vitro results [17], the selective use of CDP-DME by
Cpt1p in vivo is unexpected in view of the in vitro data
showing that the Km and Vmax values of Ept1p for CDP-DME,
CDP-MME, and CDP-ethanolamine were similar and com-
pared favorably to those of Cpt1p for CDP-DME [17]. Con-
version of CDP-DME by Cpt1p apparently outweighs that by
Ept1p in vivo, possibly due to diﬀerences in enzyme abun-
dance. Alternatively, metabolic channeling between Ept1p and
Cpt1p, and the CTP-phosphoaminoalcohol cytidylyltransfe-
rases Ect1p and Pct1p, catalyzing the previous step in the
Kennedy pathways, might be involved (cf. [40]). In this respect
it is noteworthy that the partitioning of the CDP-aminoalco-
hols over Ept1p and Cpt1p in vivo, follows that of the corre-
sponding aminoalcoholphosphates utilized by Ect1p and
Pct1p, respectively [41].
Contrary to expectation, CDP-propanolamine, the precur-
sor of the artiﬁcial phospholipid PPrN [32], was preferentially
used as substrate by Cpt1p rather than by Ept1p. Since pro-
panolamine diﬀers from ethanolamine by only one methylene
group and contains a primary amine it was expected to serve as
substrate for Ept1p and not for Cpt1p. This result implies that
the extra methylene group impairs a productive interaction of
CDP-propanolamine with Ept1p leaving it as a substrate for
Cpt1p, unless metabolic channeling is involved.
ESI-MS/MS combined with stable isotope labeling has
proven a powerful method for resolving the substrate prefer-
ences of phospholipid biosynthetic enzymes in vivo. This ap-
proach adds a new dimension to research on the many
functions of lipids in cell biology by its ability to visualize
changes in molecular species in vivo.
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